Search

Intuitive Surgical Inc

Atvērts

SektorsVeselības aprūpe

371.66 -0.47

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

366.93

Max

377.59

Galvenie mērījumi

By Trading Economics

Ienākumi

1.7M

823M

Pārdošana

122M

2.9B

P/E

Sektora vidējais

45.229

57.371

EPS

2.8

Peļņas marža

28.462

Darbinieki

17,021

EBITDA

34M

1.2B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+30.81% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 20. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-4.2B

140B

Iepriekšējā atvēršanas cena

372.13

Iepriekšējā slēgšanas cena

371.66

Ziņu noskaņojums

By Acuity

21%

79%

56 / 340 Rangs Healthcare

Intuitive Surgical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 24. aug. 19:16 UTC

News

Intuitive Surgical reported second-quarter earnings of $2.80 per share, exceeding expectations, but shares are lower since Friday's close amid broader market concerns.

2026. g. 21. aug. 19:46 UTC

News

Intuitive Surgical reports strong Q2 results with revenue up 18.5%. Shares are higher, reflecting solid guidance and a significant acquisition by Bank of New York Mellon.

2026. g. 20. aug. 19:51 UTC

Intuitive Surgical Inc shares are lower today, breaking a trend of higher closes. No specific news was identified to explain the decline.

2026. g. 19. aug. 19:26 UTC

News
Correlated Moves

Intuitive Surgical shares reached a four-week high of $404.99, trading higher during Wednesday's session, despite earlier pulling back from a session peak.

2026. g. 18. aug. 23:21 UTC

Intuitive Surgical Inc's shares are higher in after-hours trading, despite a lack of specific news. The stock remains above its 20-day moving average.

2026. g. 17. aug. 23:16 UTC

Intuitive Surgical Inc. shares showed routine trading after-market hours, remaining roughly flat since Monday's close and positioned above its 20-day moving average.

2026. g. 13. aug. 19:46 UTC

Correlated Moves

Intuitive Surgical shares are lower amid rising jobless claims, reflecting cautious market sentiment. The decline aligns with similar trends in Stryker Corp.

2026. g. 12. aug. 19:56 UTC

News
Correlated Moves
Social Media

Intuitive Surgical Inc's shares are lower today, despite Oppenheimer upgrading the stock to Outperform with a $500 price target. Concerns about competition persist.

2026. g. 10. aug. 20:02 UTC

News

Intuitive Surgical Inc. shares are higher, supported by gains in the Health Care Equipment sector, despite competitive pressures and growth guidance challenges.

2026. g. 7. aug. 23:52 UTC

Intuitive Surgical Inc. shares traded lower in after-market hours, maintaining a position within their one-month range and above the 20-day moving average.

2026. g. 6. aug. 19:36 UTC

Intuitive Surgical Inc's shares are lower today, with no specific news driving the decline. The stock remains within its one-month trading range.

2026. g. 5. aug. 19:52 UTC

Intuitive Surgical Inc shares are higher today amid cautious market sentiment following ADP's report of weaker-than-expected private sector job growth.

2026. g. 4. aug. 20:04 UTC

Correlated Moves

Intuitive Surgical Inc shares declined during Tuesday's session, continuing a downward trend seen in the health care equipment sector amid broader market pressures.

2026. g. 3. aug. 20:03 UTC

Correlated Moves
News

Intuitive Surgical Inc shares are higher as the company reports a 19% revenue increase to $2.89 billion and reaffirms full-year guidance.

2026. g. 31. jūl. 23:41 UTC

Intuitive Surgical shares are higher in after-market hours, despite a broader market decline and trading near the lower end of its one-month range.

2026. g. 30. jūl. 20:09 UTC

Intuitive Surgical Inc. shares are near unchanged amid broader market volatility and disappointing economic data, including lower-than-expected GDP growth and rising jobless claims.

2026. g. 29. jūl. 23:21 UTC

Intuitive Surgical Inc. shares declined in after-market trading, reflecting ongoing weakness and a lack of momentum following an initial peak.

2026. g. 28. jūl. 18:32 UTC

News
Correlated Moves
Social Media

Intuitive Surgical Inc shares rose after UBS initiated coverage with a Buy rating and a $500 price target, reflecting confidence in growth potential.

2026. g. 27. jūl. 20:02 UTC

Social Media
News

Intuitive Surgical partners with Deion Sanders to boost awareness of robotic surgery options. Shares are trading higher amid positive market sentiment.

2026. g. 24. jūl. 17:02 UTC

Social Media
Correlated Moves
News

Intuitive Surgical shares are advancing as The Motley Fool identifies the company as a strong buy, citing solid medium-term prospects despite competitive challenges.

2026. g. 23. jūl. 20:03 UTC

News

Intuitive Surgical shares are lower today after a significant early drop, continuing a trend of three consecutive daily declines despite an AI-focused presentation at a conference.

2026. g. 22. jūl. 18:52 UTC

News

Intuitive Surgical shares lower as Johnson & Johnson gains FDA authorization for its Ottava Surgical Robot, raising competitive concerns in robotic surgery.

2026. g. 21. jūl. 19:42 UTC

News

Intuitive Surgical Inc shares are lower as analysts express caution amid rising GLP-1 medication use and the expiration of ACA enhanced premiums.

2026. g. 20. jūl. 19:41 UTC

Social Media
News

Intuitive Surgical's price target lowered to $685 by Bernstein, yet shares are higher today amid a recovery and new extended use program launch.

2026. g. 17. jūl. 19:41 UTC

News
Social Media

Intuitive Surgical shares are lower after analysts cut price targets, with Mizuho lowering its target to $400 amid concerns over slowing procedure trends.

2026. g. 16. jūl. 23:02 UTC

News
Social Media

Intuitive Surgical shares fell in after-market trading despite strong earnings, as management cited U.S. market challenges and a Class II recall of surgical components.

2026. g. 15. jūl. 19:52 UTC

News

Intuitive Surgical reports first-quarter revenue of $2.77 billion, up from $2.25 billion last year. Shares are advancing despite a recent product recall.

2026. g. 14. jūl. 20:02 UTC

Correlated Moves
News

Intuitive Surgical shares are lower as Baird cuts price target to $525 from $610. The stock has reached a 25-month low at $395.02.

2026. g. 13. jūl. 23:11 UTC

Intuitive Surgical shares traded roughly flat in after-hours trading, showing little momentum amid broader market pressure on major tech stocks.

2026. g. 10. jūl. 20:06 UTC

Event

Intuitive Surgical Inc shares are lower as investors await Q2 earnings, with analysts estimating EPS of $2.41 and revenue of $2.8 billion.

Salīdzinājums

Cenas izmaiņa

Intuitive Surgical Inc Prognoze

Cenas mērķis

By TipRanks

30.81% augšup

Prognoze 12 mēnešiem

Vidējais 488.68 USD  30.81%

Augstākais 685 USD

Zemākais 366 USD

Pamatojoties uz 24 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Intuitive Surgical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

24 ratings

20

Pirkt

3

Turēt

1

Pārdot

Noskaņojums

By Acuity

56 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat